Related Experiment Videos
HFE-associated hereditary hemochromatosis
E J Eijkelkamp1, T R Yapp, L W Powell
1Queensland Institute of Medical Research, Brisbane, Australia.
Summary
Hereditary hemochromatosis, a common iron metabolism disorder, affects 1 in 200-400 people. Early diagnosis and treatment ensure normal life expectancy, but widespread genetic testing requires further study.
Area of Science:
- Genetics
- Metabolic Disorders
- Public Health
Background:
- Hereditary hemochromatosis is a prevalent inherited iron metabolism disorder.
- Prevalence ranges from 1 in 200 to 400, with carrier rates of 1 in 7 to 10.
- The HFE gene, identified in 1996, is linked to the condition, with the C282Y mutation being a primary cause.
Purpose of the Study:
- To review the current understanding of hereditary hemochromatosis.
- To assess the potential for population screening based on genetic discoveries.
- To evaluate the implications of widespread genetic testing.
Main Methods:
- Literature review of hereditary hemochromatosis studies.
- Analysis of prevalence and genetic mutation data.
- Evaluation of World Health Organization and Wilson and Jungner screening criteria.
Main Results:
- The C282Y mutation in the HFE gene accounts for most hereditary hemochromatosis cases globally.
- Early diagnosis and treatment lead to normal life expectancy.
- The disorder meets established criteria for population screening.
Conclusions:
- The discovery of the HFE gene enables widespread genetic testing possibilities.
- Further research is needed to address logistical, psychological, and social consequences before population screening.
- Incomplete genotype expression necessitates careful consideration for screening strategies.